Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

TfR-targeted PVA-doxorubicin/albumin-sorafenib core-shell nanomedicine

Based on

1 Articles
2014 Most recent source

Composition

1

PVA-doxorubicin nanoparticles

Type Nano Material
Formula
Role core
2

human serum albumin

HSA
Type Biomolecule
Formula
Role layer
3

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

sorafenib SFN SOR SF
Type Single Compound
Formula C21H16ClF3N4O3
Role loaded material
4

human holo-transferrin

Tf
Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
  • human serum albumin
  1. CRAHIPgERz23WQ4xWfFfZAc6tdocRu
  2. D1DUNM2s
Product

TfR-targeted PVA-doxorubicin/albumin-sorafenib core-shell nanomedicine

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial